MedTrace Logo

Diagnosis of Gastric Intestinal Metaplasia With High Definition Endoscopy and Optic Enhancement

NCT02725034 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2016-03-31

No results posted yet for this study

Summary

The purpose of this study is to assess whether high definition endoscopy with Optic Enhancement can reduce the biopsy number needed per patient for the detection of gastric intestinal metaplasia without the loss of corresponding diagnostic yield

Conditions

  • Gastric Intestinal Metaplasia

Interventions

DEVICE

Standard endoscopy

DEVICE

High definition endoscopy with Optic Enhancement

Sponsors & Collaborators

  • Shandong University

    lead OTHER

Principal Investigators

  • Yanqing Li, PhD. MD. · Department of Gastroenterology, Qilu Hospital, Shandong University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02725034 on ClinicalTrials.gov